stocktools
Offerings // Silexion Therapeutics Corp

SLXN offering history

Every offering-related filing in Silexion Therapeutics Corp’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 281 filings back to May 9, 2024.

Last executed offering
Sep 29, 2026
8-K — priced deal (shares or notes)
Last registration (announced)
Oct 28, 2026
S-3 — capacity, not a sale
Executed, last 12 months
3
424B pricings + 8-K 3.02 sales
Registered, last 12 months
4
S-1/S-3/F-series registrations
DateFilingWhat it means
Nov 9, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Oct 28, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Sep 29, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Sep 29, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 13, 2026424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Aug 11, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 10, 2026S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Aug 7, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jun 18, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 18, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 12, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
May 15, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 11, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 11, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Oct 31, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Sep 30, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 26, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Sep 15, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Sep 12, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Sep 11, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 5, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Sep 4, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 4, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 26, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Aug 12, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 12, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 12, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 1, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 1, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 1, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 29, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 13, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 13, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 6, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 1, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 29, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 29, 2025AW →WITHDRAWNRegistration withdrawn
Apr 29, 2025AW →WITHDRAWNRegistration withdrawn
Apr 25, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 1, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
SLXN offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full SLXN workspace →
SLXN offering FAQ

When did SLXN last execute an offering?

Per SEC filings, Silexion Therapeutics Corp's most recent priced offering document is a 8-K filed 2026-09-29. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did SLXN last announce or register an offering?

The most recent registration is a S-3 filed 2026-10-28. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.